Repositioning Candidate Details
| Candidate ID: | R1065 |
| Source ID: | DB06624 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | Taranabant |
| Synonyms: | Taranabant |
| Molecular Formula: | C27H25ClF3N3O2 |
| SMILES: | C[C@H](NC(=O)C(C)(C)OC1=CC=C(C=N1)C(F)(F)F)[C@@H](CC1=CC=C(Cl)C=C1)C1=CC=CC(=C1)C#N |
| Structure: |
|
| DrugBank Description: | -- |
| CAS Number: | 701977-09-5 |
| Molecular Weight: | 515.96 |
| DrugBank Indication: | Investigated for use/treatment in obesity. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I14 | 9970 | Obesity | An overnutrition that is characterized by excess body fat, traditionally defined as an elevated ratio of weight to height (specifically 30 kilograms per meter squared), has_material_basis_in a multifactorial etiology related to excess nutrition intake, decreased caloric utilization, and genetic susceptibility, and possibly medications and certain disorders of metabolism, endocrine function, and mental illness. https://en.wikipedia.org/wiki/Obesity | disease of metabolism/acquired metabolic disease/ nutrition disease/overnutrition | Details |